Skip to main content
SpringerLink
Log in

Human papillomavirus vaccine recombinant quadrivalent

First report of anaphylaxis: 10 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Brotherton JML, Gold MS, Kemp AS, McIntyre PB, Burgess MA, Campbell-Lloyd S, New South Wales Health HPV Adverse Events Panel.Anaphylaxis following quadrivalent human papillomavirus vaccination. Canadian Medical Association Journal 179: 525-533, No. 6, 9 Sep 2008 - Australia

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Human papillomavirus vaccine recombinant quadrivalent. React. Wkly. 1220, 14–15 (2008). https://doi.org/10.2165/00128415-200812200-00043

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812200-00043

Keywords

Search

Navigation